Introduction Radcliffe
A strikingly modern account of multiple sclerosis Infirmary Prize (MS) was given by Jean Martin Charcot1, working in Pathology1985 at the hospital of the Salpetriere, Paris, in 1868 although the lesions had been illustrated somewhat earlier2. Gharcot's great contribution was to correlate the clinical signs of the illness with the pathological changes in the nervous system seen at necropsy, thereby enabling him to delineate 'sierose en plaques' as a distinct disease entity. At this time, medical ideas of causation were still dominated by humoral factors, and Charcot speculated that the paralysis might result from exposure to cold and damp, physical injury or emotiQnal stress. In the ensuing decade Koch and Pasteur did much of their pioneering work in microbiology and thus it was not surprising that by 1884 Pierre Marie, Charcot's student and successor in the Chair of Neurology at the University of Paris, should postulate an infective aetiology for multiple sclerosis3. A century later the cause of MS is still not known with any certainty, though at various times reports have appeared implicating spirochaetes, protozoa, bacteria, and viruses. Evidence has accrued from several disciplines to suggest that infective agents play at least an accessory role in the inception of the disease, the current front-runners being measles virus and canine distemper virus. It is important to note that in virtually all series of MS cases reported, the diagnoses have been made on clinical grounds without recourse to a pathognomonic diagnostic test or to pathological verification. Schemes of diagnostic criteria have been introduced but are not universally accepted.
The use of evoked potentials may obviate this problem in the future4.
Epidemiology
Undoubtedly the strongest evidence in favour of an infective aetiology for MS comes from epidemiological studies. MS is rarely diagnosed in individuals under 15 or over 55 years of age, with a peak age of onset around the age of 30. Thus the age-specific onset curve is unimodal and resembles that of common infectious diseases which produce life-long immunity, but its peak is much later than for other parasitic and infectious diseases. It is certainly not the age-specific onset curve seen in most degenerative, genetic and neoplastic diseases. Neither is it unique, however, to the infectious process, being seen also (quite 0141-0768/86/ logically) in reproductive diseases of women and 070412-06/$02.00/O chronic rheumatic heart disease. For unexplained°1 986 reasons it is also seen in migraine, schizophrenia The Royal and sinusitis. Therefore, though suggestive, the age Society of of onset cannot be considered specifically indicative Medicine of an infectious aetiology.
Approximately 200 studies ofthe geographical distribution of MS have been conducted. They show three zones of frequency or risk, ranging from the high frequencies of 30-80 cases per, 100 000 population in northern Europe, Canada, northern USA, southern Australia and New Zealand, through medium risk (5-25 per 100 000) to the low-risk areas of Africa and Asia (less than 5 per 100 000 population). The relationship of frequency to latitude is not bntirely consistent: for example, there is a very low prevalence in Japan (2 per 100 000). Nonetheless, there is a clear north-south geographic gradient in the USA. This unique geographic distribution suggests the action of some environmental factor cauping the disease, but such a factor cannot fully explain it. The data referring to latitude can just as easily be interpreted as showing a predisposition among populatons of predominantly Germanic origin (including Anglo-Saxons and Scandinavians), since all highand medium-risk zones have predominantly whiteipopulations. Regardless of?esidence in the USA, Negroes have half the risk of disease compared to whites; Japanese Americans and possibly Red Indians also have lower rates but still demonstrate geographic gradients5. MS seems to be largely a white man's burden. So there seems to be some genetic influence on aetiology, as well as environmental. This might help reconcile the variable distribution of the disease with the known ubiquity of the measles virus. A genetic susceptibility to the disease is confirmed by studies of tissue antigens which show that MS is associated with HLA-B7, -Dw2, and -DRw2 in northern European and North American Caucasians. There is a decrease in the strength of this association from north to south Europe, and specifically different associations are found in Mediterranean and Japanese populations of MS patients6. It is believed that the biological role of HLA is concerned with immune responsiveness, so it is possible that MS is due to an imbalance between the potency of infective environmental agent(s) and genetically determined host responses.
The fate of migrants between regions of differing risk is vital to the interpretation of distribution. Broadly, migrants retain much of the risk of their birthplace. However, the risk is not defined at birth since MS death rates for migrants born in one risk area and dying in another are intermediate between the rates characteristic of their birthplaces. Dean7 noted that the majority of MS patients in South Africa were immigrants from UK or northern Europe, even though they only made up 10% of the population. Dean and Kurtzke8 showed that immigration before the age of 15 seemed to afford some protection from MS onset, the prevalence rate in such immigrants tending toward that of white English-speaking natives but still remaining well above that of white Afrikaans-speaking natives. Alter et al.9 found a similar result (admittedly with a small sample size) for Europeans migrating to Israel: only for immigrants aged less than 15 did the prevalence of MS fall below that expected for their native land. Afro-Asian immigrants to Israel, moving between two low-risk areas, showed no change in prevalence.
Migrant studies have many problems which may confound the unwary and produce spurious results. They depend on a sufficiency of people changing residence from one risk area to another; the ages at immigration; the length of stay in the new land; and the ages at prevalence day. The population at risk is a function of all these variables and therefore is hard to determine10. Despite these caveats, the available data are good enough to show that risk of MS is determined by exposure to an environmental factor around adolescence, well before the clinical onset of disease. These findings in the early 1970s coincided with the elucidation of slow viruses, which-provide a working explanation for a disease caught at around adolescence but with a long latency before clinical expression.
The mooted analogy with poliovirus was effectively refuted by the migrant data. If, as with polio, the virus was common in areas of low prevalence, there being a high level of herd immunity, then migrants from high prevalence areas would be expected to suffer an even greater incidence of disease. Migration to low prevalence areas in fact has some protective effect if undertaken before about age 158.9. Thus the environmental factor appears either more common or more effective in geographic areas where disease itself is more common. Obeying this 'simple' or 'prevalence' hypothesis, the cause of MS is more likely to be found where the disease itself is more common.
The occurrence of MS in first-degree relatives of patients is about 15-20 times the expected rate, the greater rate being more striking-in siblings than in parents. Such a familial aggregation is againstia predominantly genetic aetiology and favours a common environmental exposure. The fact that there is no increased conjugal occurrence supports the thesis, established in migrant studies, that disease is related to pre-adolescent or adolescent exposure. Twin studies show an even higher concordance rate, though there is no significant difference between monozygotic and dizygotic twins. Schapira et al."1 used a method of analysis based on the period during which siblings, two or more of whom had MS, shared a common residence and concluded that MS is acquired at about 14 years, which neatly tallies with the migrant data. The slight female preponderance of MS cases is not obviously amenable to explanation by an infective, environmental, aetiological factor.
Other environmental factors besides microorganisms have been considered at times as potentially related to MS: diet, climate, amounts of sunshine, even breastfeeding. However, despite radical changes in diet, housing and sanitation in areas of high and low prevalence, there has been no evidence of a change in prevalence over time. Furthermore, two populations sharing similar climate, socioeconomic status and genetic background, on the Orkney and Shetlatid Islands and on the Faroe Islands, have widely different prevalence rates for MS: up to 300 cases per 100 000 population in the former (the highest rate in the world) and none in the Faroes before 1940 (and possibly since 1970).
MS is possibly more common among persons of higher socioeconomic status12. Alter13 proposed that MS might be an age-dependent host-response-to measles, since in the tropics where MS is rare measles is acquired early in life, whereas in temperate areas measles tends to be caught later, around age 5. Based on admittedly meagre evidence it was suggested that the later a high level of herd immunity to measles was achieved, the higher the rate of MS; such levels of immunity tend to build up later in hygienic communities.
No conclusive evidence of a seasonal variation in onset has been advanced, but Brody"' pointed out that such a finding might favour a viral!aetiology as the circulation of-respiratory and myxoviruses is increased during the winter months in temperate climates. The ideal situation in which to search for clues to the aetiology of MS would be where a dramatic change in its incidence occurred. Kurtzke and Hyllested"' reported that 24 cases in the Faroe Islands between 1943 and 1960, though similar to other series in clinical characteristics, showed striking anomalies in occurrence over time; in fact they fulfilled the criteria for a point source epidemic: there was a disease occurrence clearly in excess of normal expectancy And likely to be derived from a common or propagated source. In fact, MS had suddenly appeared and just as suddenly disappeared, the result perhaps ofa single cause introduced to the Faroes before 1943. The only major event in the islands in these years was the occupation by British troops from 1940 to 1945, and it was suggested that the disease was introduced by the British troops or their impedimenta. At least on the Faroes, MS seemed to be a transmissible infectious disease. However, measles was recurrently epidemic on the islands over the previous 90 years, yet there were no previous outbreaks. A similar clustering of cases was reported in Icela-nd for the 10 years or so after 1945, but there was no abrupt appearance/ disappearance as in the-Faroes 6. From the annual incidence rates it seemed likely that an epidemic had occurred. In Iceland we may possibly see the 'critical mass' of population required to maintain the disease within a relative geographic isolate. Occupation by British, Canadian, and American troops occurred between 1940 and 1945.
Cook and Dowling"7 showed in a questionnaire survey in New Jersey that in age, sex, and socioeconomic matched populations of MS patients and controls, exposure to house pets was significantly higher in the MS group. This retrospective casecontrol study was prompted by the observation of 3 sisters living together in their childhood home all developing MS in 1974 subsequent to their dog suffering an acute encephalopathy in 1973. It was then discovered that canine distemper was non-exigtent on the Faroes before 1939, but an epidemic oecurred in 1940 following the arrival of the British, but prior to the outbreak of MS: it is known that many of the British-officers brought dogs with them to the Faroes. Hence the suggestion that canine distemper virus (CDV), a paramyxovirus similar to measles virus, might cause MS18. It could also be implicated in the very high rates of MS on the Orkneys and Shetlands, since it was endemic there, and a large distemper epidemic in Iceland in 1941-2 preceded the MS epidemic reported there. This latter evidence was challenged by Nathanson et al."9 who showed that a high prevalence of MS occurred in certain regions of Iceland where distemper had been essentially absent for 70 years. Also the elimination of dogs in urban Reykjavik had failed to prevent a high incidence of MS there. Sylwester and Poser20 questioned the validity of the association between house pets and MS, and using a similar questionnaire were able to show a statistically significant association between the disease and exposure to cows and/or chickens in a semirural population in Vermont. Undaunted, Cook and Dowling2' have recently documented an outbreak of MS in Sitka, Alaska, which they claim was predicted by the animal distemper/MS hypothesis: all 3 cases followed a canine distemper epidemic in 1965.
The findings of epidemiology can do no more than point us in a particular direction, by showing temporal and spatial associations between factors without necessarily implying a causal relation. Epidemiological data can only serve as indirect evidence for a viral aetiology in MS, and such a causation can only ever be consistent with the data. This does not invalidate the method, as striking associations may be revealed with important consequences for disease prevention (see, for example, Doll and Hill22). Nonetheless, it is quite easy to show 'significant' associations in the statistical sense20, and statistical data are liable to nonsensical manipulations. The epidemiological facts of MS are sufficient to show involvement of an environmental factor, but not that it is viral. They also show that at least two factors are involved in the aetiology, of which both may be viral, both causal, one causal and one preventive, one ubiquitous and one rare, and so on. With multiple determinants the whole problem becomes more involved and no easy answers are forthcoming.
Clinical studies implicating viruses A completely different approach has been to study the tissues of individual patients suffering from multiple sclerosis to search for clues to the aetiology of the disease.
Adams and Imagawa23 were the first to report slightly higher levels of measles-neutralizing and complement-fixing antibodies in the sera of MS patients. Up to 1976, 31 of 35 publications addressed to this question, using a variety ofdifferent antibody detection systems and antigen preparations, had confirmed the original finding. However, the elevation of measles antibody titre is modeston average twice that of controls. Statistically significant differences are only found with aggregate data. The inconstant finding of raised measles virus (MV) antibodies can be reconciled with an aetiological role for MV if the virus were present in an unusually masked, defective, or latent form24. Nor is the finding specific, since similarly elevated levels are found in systemic lupus erythematosus, Reiter's syndrome, and chronic liver disease. Far from reflecting an aetiological role for measles virus, the raised titres could merely be an epiphenomenon consequent on, rather than causal to, the disease process. At various times reports of higher titres for a wide variety of other viruses in MS sera have been made including type C influenza, herpes simplex, parainfluenza 3, mumps, varicella zoster, vaccinia, rubella, Epstein-Barr virus (EBV) and adenovirus. Most recently a claim has been made (perhaps predictably) for human T-cell lymphotropic viruses (HTLV), one variant of which causes the acquired immune deficiency syndrome (AIDS)25. However, the elevations in titre are not so consistently found as for MV, and are not therefore simply the result of a hyperactive immune system. Panelius et al. 26 reported that siblings of MS patients and unrelated controls in high-risk areas also have tendencies to high MV antibody titres. This was accounted as further evidence for exposure to an environmental agent and suggests that the raised MV titre is not an epiphenomenon. At least a fourfold change in IgG antibody titre in paired sera is needed in order to have acceptable serological evidence of acute viral infection, but the finding of IgM27 would be presumptive evidence of recent or persistent infection. These results were later found to be artefactual, due to rheumatoid factor reacting with IgG to MV28. MS sera have higher titres of neutralizing antibodies to both MV and CDV than controls, but only for MV is the difference significant29. The antigenic similarity of MV and CDV may cause cross-reactions in the serological testing, so further muddying the water.
Serological surveys must be interpreted cautiously since titre differences between MS patients and controls could simply reflect HLA type, a high serum IgG, or a hyperimmune state. Due to the prolonged latent period indicated by the epidemiological studies, a significant antibody response when disease finally became clinically manifest would be unexpected, particularly for a common virus; only if a previously unknown or rare virus caused the illness would the antibody response be pathognomonic. Furthermore, during a persistent virus infection the host antibody response may be bypassed, diminished or restricted. Thus the absence of an antibody response does not eliminate any virus(es) that may for other reasons be considered as potential aetiologic agent(s) of MS30.
Studies of antiviral antibodies in MS cerebrospinal fluid (CSF) have been similarly unrewarding: there is an increased MV titre, and the serum: CSF ratio suggests antibody production in the central nervous system (CNS) or CSF31. There is no satisfactory evidence that the increased serum antibody is due to excess intracranial production spilling over to serum. Abnormal serum:CSF ratios have been reported at various times for rubella, vaccinia32, herpes simplex, and mumps, sometimes in the same patient, suggesting an alteration in the permeability of the blood-brain barrier. Williams et al. 33 reported an increased CSF IgM in 40% of MS patients but of unknown antigenic specificity. Such levels could merely represent an increase in immune responsivity with an underlying genetic basis or secondary to the MS process.
The oligoclonal bands found in the CSF of 65-95% of MS patients may represent a primary response to either persistent viral infection or a CNS autoantigen. Such banding is also seen in herpes encephalitis, mumps meningitis, measles encephalitis, subacute sclerosing panencephalitis (SSPE) and neurosyphilis to name but a few, and also in experimental allergic encephalomyelitis (EAE), at one time thought to be a model of MS. It has not been possible to correlate MV-specific antibodies with the oligoclonal bands of IgG: only a small portion of oligoclonal IgG can be removed from MS CSF after absorption with MV antigen. Also the oligoclonal bands may be secondary as in the genetic metabolic disorder of adrenoleukodystrophy.
Studies of cellular immunity in MS patients have sought to demonstrate a selective impairment of lymphocyte reactivity to viruses as compared to controls, so providing a potential explanation for chronic infection. Utermohlen and Zabriskie34 described significantly reduced migration inhibition of MS leukocytes in the presence of MV, and although this was confirmed in other laboratories it was shown to occur at only one dilution of measles antigen and to be nonspecific, occurring also with mumps and parainfluenza viruses. A significant correlation was found between lymphocyte transformation to MV and vaccinia virus and degree of disability in the MS patient. Thus it was concluded that the deficient cellular immune responses to MV and possibly also to other viruses are consequences of the disease itself and not a causal factor; there is no difference in the capacity for blast transformation between MS and neurologic control lymphocytes. Similarly, MV antigen skin anergy in MS patients is also secondary since hyporeactivity is seen in the neurologic diseases control group. Thus no unequivocal difference has been found in the response of MS lymphocytes to the viral antigens tested, so these studies cannot be used to support the candidacy of the virus in MS aetiology. They are also subject to technical variability regarding method of lymphocyte isolation, purity of antigenic preparations, and quantity of antigen relative to the number of lymphocytes, using lymphocytes from patients with different disease activity status, and concurrent drug therapy.
Attempts at direct isolation have produced claims from time to time for rabies, herpes simplex (HSV), measles35, and parainfluenza type 136. In general, such reports are unconfirmed and may represent contamination or spontaneous unrelated infections of the laboratory animals/cell lines/patients. In addition to these findings, there have been numerous unsuccessful attempts to culture brain, lymph nodes, and lymphocytes from patients, or to inoculate the disease to a wide range of experimental animals. The absence of a satisfactory animal model has certainly retarded research work in MS.
A wide variety of structures have been visualized by means of electron microscopy. Prineas37 saw intranuclear tubular structures resembling myxovirus nucleocapsids in fresh plaque tissue, but these filamentous strands are also seen in progressive multifocal leukoencephalopathy (PML), herpetic encephalitis, and Guillain-Barre syndrome and thus are believed to be non-viral nucleoproteins unusually preserved. Tanaka et al.38 saw 5565 nm doughnutshaped particles in rough endoplasmic reticulum cisterns in one of 12 MS patients studied, which they believed resembled the morphology of coronaviruses, the causative agents of visna. Use of hightitred, well-defined and properly absorbed antisera probes to identify viral antigen by way of radioimmunoassay, immunofluorescence, and immunoperoxidase" have to date produced no evidence of MV, CDV, mumps, HSV, or parainfluenza in MS brains. Haase et al."0 used a tritium-labelled probe that detected MV nucleotide sequences for hybridization in situ to sections of brain tissues from MS patients, and saw two foci in one of 4 cases. The probe, prepared by reverse transcription of full length MV RNA, was shown to be specific since prior digestion with ribonuclease reduced the grain counts to the level of uninfected control cells. This finding could merely represent an adventitious agent in a debilitated host on steroid therapy. Similarly, Koprowski et al. 25 have used specific HTLV-1 probes for in situ hybridization with RNA in MS CSF cell cultures, with positive results in 4 out of 8 patients studied.
In general, evidence of a viral aetiology from pathological studies, serology, lymphocyte reactivity to viral antigens, and identification of virus in MS tissues, is less convincing than epidemiological considerations. All the findings are liable to an equivocal interpretation.
Potential viral causes of multiple sclerosis
Although there is no satisfactory animal model for MS, the clinical and pathological features of the disease are not inconsistent with a viral infection. Individual features of MS such as long incubation period, relapsing/remitting time course, and myelin destruction with relative sparing of axons are seen in other viral diseases of man and animals. The prototype slow infections first described in Icelandic sheep are scrapie and visna; the latter is a chronic inflammatory demyelinating disease caused by a coronavirus, whereas scrapie is a non-inflammatory degenerative disease caused by an unconventional agent the nature of which has still to be fully elucidated"" 42. A number of human neurological diseases have also been shown to represent slow infections: the spongiform encephalopathies kuru and Creutzfeldt-Jakob disease are caused by unconventional agents similar to scrapie 'virus', whereas PML and SSPE are due to conventional viruses as in visna. A number of factors implicate measles virus as causal in SSPE: virus-like particles visualized in eosinophilic inclusions in areas of chronic inflammation in grey and white matter; the consistently raised anti-measles antibody in serum and CSF; and the demonstration ofMV antigen inbrainby immunofluorescence. However, in only 50% of cases could MV be recovered in cell culture. SSPE and PML may show periods of stabilization and even transient improvement but the viruses that par excellence cause dramatic remitting/relapsing disease in man are the herpesviruses, as exemplified by recurrent herpes labialis or genitalis due to HSV; recrudescence of chicken pox as herpes zoster; and activation of cytomegalovirus (CMV) causing acute pulmonary disease in the immunosuppressed. Attempts to implicate HSV in MS have been unsuccessful. The point is that known viral infections can follow a similar time course to MS.
There are many potential ways in which viruses could cause demyelination. Selective infection of oligodendroglia by papovaviruses is seen in PML; the fact that this disease is most frequently seen in immunosuppressed patients suggests that the pathogenesis is a direct cytopathic effect rather than being immune-mediated. The neurotropic strain (JHM) of mouse hepatitis virus also exerts a direct cytopathic effect on glia. A modification of the glial cell membrane secondary to viral infection could produce a reaction against viral antigens or sensitization to the host myelin antigens: experimental allergic encephalomyelitis is due to -a reaction against myelin basic protein. Demyelination could also occur without the cells being infected if virus and myelin sheath shared cross-reacting antigens or the membrane were modified without infection. These are all examples of immunopathological mechanisms.
The animal distemper/MS hypothesis is biologically credible since there are remarkable similarities between the varied systemic and neurological diseases caused by CDV in dogs and MV in man, e.g. the resemblance of the inflammatory perivenular demyelination in distemper encephalitis with that seen in measles encephalitis. CDV can be inoculated across species barriers43. The host immune response is suspected of playing a role in myelin destruction in CDV, and in post-infectious encephalomyelitis in man. Theiler's mouse encephalomyelitis virus (TMEV), when inoculated intracerebrally to mice, can cause a late chronic progressive demyelinating infection which resembles MS in its pathology"4.
Myelin breakdown appears to be immune-mediated, because immunosuppression with cyclophosphamide and antithymocyte antisera prevents development of the lesions. An alternative immunopathologic mechanism is suggested in nude mice where demyelination occurs without a contribution from the T-lymphocyte system45.
The histological appearances of the lesions in MS strongly suggest that they are immune-mediated39'46. If such is the case then the welter of apparently inconsistent and conflicting data on viral involvement can be reconciled by proposing that all these agents act, alone or in concert, through a common immune-mediated pathway, a sort of pathological 'final common pathway'. Such a mechanism has already been proposed for the Guillain-Barre syndrome: this is an inflammatory demyelinating disorder of peripheral nerves, also known as 'idiopathic polyradiculoneuropathy'. It can be initiated by a number of infectious agents (e.g. CMV, EBV, mycoplasma, herpesvirus, Campylobacter jejuni) but has an immunological pathogenesis; the evidence supporting the major importance of autoantibodies and of immune complexes continues to increase47. It may in some instances become a chronic remitting/relapsing disease.
Conclusion
Considering all the evidence, it is clear that no agent-can be convincingly linked to MS at present, the evidence available for a viral aetiology being circumstantial and fragmentary. Indeed, it is far from accepted that MS is caused by a virus, let alone any specific one. Epidem-iology-has established the presence of an environmental-factor operative at around adolescence, and perhaps transmissible in certain circumstances, but it is not established to be viral, albeit that an infectious agent would best fit the data. Direct evidence for viral involvement is at best fragile, all the immunological data being potentially no more than epiphenomena to the disease process.
Perhaps the most cogent 'evidence' at present is from analogy: viruses have been clearly associated with four chronic neurological diseases in man: kuru, Creutzfeldt-Jakob disease, PML and SSFE.
Elucidation of the aetiology of these diseases all required advances in methodology, and a defective virus not amenable to isolation or identification by current techniques may still be shown to cause MS.
The clinical and pathological features of MS are not inconsistent with a viral infection, and although there is no adequate animal model of MS there are a number of animal and human viral illnesses with one or other of the features of MS. Thus there are reasons for thinking MS has a viral aetiology even though existing evidence is poor. Model systems, whilst still poorly understood, may provide some insight into the viral and host factors that are responsible for subacute or chronic CNS infections accompanied by demyelination. It is possible that multiple agents act through a common immunemediated pathway, a situation analogous to that described in Guillain-Barre syndrome" where there is an inflammatory demyelination of unknown aetiology in peripheral nerves. This hypothesis would also be consistent with the involvement of both genetic and environmental factors in disease aetiology. However, a consistent hypothesis is not necessarily a correct one.
The causation of MS may be viewed as a number of steps or links in a chain, a so-called 'multifactorial' aetiology. At present the precise nature of these steps is unknown, but this does not necessarily prevent effective prophylaxis and/or treatment from being instituted. History teaches us that methods were available to prevent at least two major infective killers long before their microbiological cause was known, viz., smallpox49 and puerperal sepsislo.
The exact cause of diabetes mellitus remains unknown, yet effective treatment is available. Obviously it is less satisfactory to work on such an empirical basis and, particularly in the case of MS, far too many 'miracle cures' have been announced only to be subsequently proven worthless. Hence there is a need for continued research into a potential viral cause for MS. It is possible that fundamental virological questions will need to be answered by the study of virus-associated diseases before progress is made in MS research.
